Surface Active (UK) prepares for near patient testing (NPT) partners
This article was originally published in Clinica
Surface Active (UK) has developed a near patient testing technology based on transducing antibodies. The antibodies induce enzyme activity directly in the presence of target antigens, and this generates a colour change. A variety of untreated liquid substrates, including blood and amniotic fluid can be used and 1-2 ml is sufficient to perform up to three reactions, including controls.